What Is-Charity-Bayonne-Curing Type 1 Diabetes
View our Web Page http://getinvolved.jdrftype1.com
Video Credits can be found here http://broadcaster.beazil.net/public/credits/youtube/videos/44349 Bayonne is a largely working-class city, with a mix of private houses and small apartment buildings, just south of the larger, more built-up Jersey City and right across the Bayonne Bridge from the North Shore of Staten Island . The city is not a usual tourist destination for daytrippers from New York City, but it does have the authenticity of a suburban town with a relatively low-density, often tree-lined urban feel that harkens back to the times before gentrification. And like some of the lower-density neighborhoods in Brooklyn, Bayonne has many churches. Type 1 diabetes (T1D) kills the body’s beta cells that produce insulin which gives us the energy we need for everyday life. JDRF’s vision, the Beta Cell Restoration Program, will not only stop the autoimmune attack but also return the number of beta cells to a normal level. JDRF is developing vaccines that will re-train the immune system to eliminate autoimmunity and leave the beta cells alone. Type 1 diabetes (T1D) can occur in anyone—not just kids. If you or an adult you know has recently been diagnosed with T1D, check out the JDRF T1D Care Kit, a free resource containing information and tools to educate, support and inspire newly diagnosed adults. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services JDRF’s research goal is to discover, develop, and deliver advances that progressively remove the impact of T1D from people’s lives until we find a cure. JDRF is driving research across the entire scientific spectrum, from discovery in the laboratory to delivery of new technologies and treatments to people with T1D. The full impact of JDRF’s research investment extends well beyond our direct funding. Now more than ever, we see the value in leveraging partnerships with academia, industry and clinicians to ensure that the most promising research opportunities are funded and accelerated. JDRF often provides early-stage funding to research projects, and the results of those projects often lead to follow-on participation from many other entities – both other not-for-profit funders and corporations. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
Inform yourself at http://jdrf.org/blog/
Show us if you like our Google Plus account https://plus.google.com/110620633690555176280/
Leave us a comment on https://www.youtube.com/user/jdrfonline
Join with us at our Facebook account https://www.facebook.com/myJDRF
Check our Twitter account https://twitter.com/JDRFTypeOne
Become our followers at https://www.linkedin.com/company/jdrf
Get familiar with our Instagram account https://www.instagram.com/jdrfadvocacy/
Check our Pinterest account https://www.pinterest.com/jdrfadvocacy/
In summary, here are the main points:
Battleship New Jersey,T1D patterns,Cure,gestational diabetes mellitus,diabetes care concepts,DILfrequency study,Special Diabetes Program,treatment,preventive therapies,insulin strength,Cure Diabetes,Oral Glucose Tolerance Test,DKA,diabetes diagnosis,juvenile diabetes,sulfonylurea,Standards of Medical Care in Diabetes,permanent insulinopenia,diabetes prevention program,antihyperglycemic agents,CGM,diabetic,Glucose Modulating Agents,make a donation,rosiglitazone,Get Personal Support,Levemir,engage,Novolin N,A1C,Diabetic Eye Complications,OGTT,NRTIs,using insulin,“All-Star” charity,Estrogen in Type 1 Diabetes,Advocacy,amputation,Research Grants,T1D complications,at-risk relatives,The Hyperglycemia and Adverse Pregnancy Outcome Study,GMP,World diabetes day,insulin lispro,LDL Cholesterol,life-changing breakthroughs,insulin-dependent diabetes mellitus,hypoglycemic episodes,Understanding Type 1,ketosis,eAG,Diabetes.